- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07762248
Impact of Minimally Invasive Endodontic Treatment on the Prognosis of Mandibular Permanent Molars With Necrotic Pulp and Apical Periodontitis
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Phase 2
- Phase 3
Contacts and Locations
Study Locations
-
-
Asyut Governorate
-
Asyut, Asyut Governorate, Egypt
- Faculty of dentistry, Assiut university
-
Contact:
- Mohamed Ashraf Abdeen, Msc
- Phone Number: 00201006518663
- Email: M.abdeen@dent.aun.edu.eg
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Participants with free medical history (category: American Society of Anaesthesiologists class I) from either gender aged from 20 to 50 years old.
- Necrotic lower first molars with four root canals (two mesials and two distals).
- Teeth have a periapical radiolucency with a diameter of 2-4 mm in CBCT images.
- Teeth show root curvature of 10°-20° as described by Schnider.
- Participant that indicated for single visit root canal treatment.
Exclusion Criteria:
- Calcified or non-negotiatable teeth.
- Participants who cannot apply for the follow-up schedule.
- Teeth that show any signs of cracks or vertical root fractures.
- Teeth that show less than 50% of sound coronal tooth structure.
- Periodontally affected teeth.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Traditional group
In this group traditional access cavity and canal preparations is done
|
Root canal treatment is done
|
|
Active Comparator: Minimally invasive group
In this group conservative access cavity and minimally invasive root canal preparation is done
|
Root canal treatment is done
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Success rate
Time Frame: 1 year follow up
|
A case is deemed successful if there is no clinical signs and symptoms of infection or inflammation and radiographic bone healing. The success rate for each group will be determined by the ratio of successful cases to the total number of cases in that group. |
1 year follow up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Healing of periapical lesion
Time Frame: 1 year
|
The change in the size of periapical radiolucencies will be assessed through a comparison of CBCT images taken preoperatively and at the 12-month follow-up.
This evaluation will be conducted by two independent operators who are not aware of the treatment group assignments to ensure unbiased results.
|
1 year
|
|
Bacterial load
Time Frame: Within 2 days after intervention
|
The bacterial levels within the root canals will be quantified at two critical stages of the treatment process: S1: Immediately following the creation of the access cavity, prior to initiating any cleaning or shaping procedures. This step is crucial for determining the initial bacterial load present in the root canal system. S2: Following irrigant activation. This measurement will provide insight into the efficacy of the cleaning and shaping procedures, as well as the irrigation protocol, in reducing the bacterial population within the canal. These bacterial samples will be collected using sterile a three size #15 paper points which will be inserted into the canals to absorb the canal contents. This method ensures a standardized approach to bacterial sampling at these specified stages of the treatment. |
Within 2 days after intervention
|
|
Treatment duration
Time Frame: During procedure
|
The total time taken to complete the treatment procedure, from the beginning of the access cavity preparation to the completion of obturation, will be meticulously recorded for each case.
|
During procedure
|
|
Iatrogenic errors
Time Frame: During procedure
|
Any occurrences of iatrogenic errors, such as instrument separation, will be noted and recorded.
This data will provide insight into the potential risks associated with each treatment approach.
|
During procedure
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Minimally invasive endo
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.